Company profile
THC Therapeutics, Inc.
OTC: THCT · Healthcare · Drug Manufacturers - Specialty & Generic
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ 24GM —SS 21
v0.1 · 25/100 weight · pillars only
↑ disclosure history, listing tenure · ↓ workforce scale, filing timeliness
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$811.6k
Employees
1
as of 2026-08-29
Market cap
$23.3k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02024
Net income-$811.6k-$811.6k2024
Operating income-$542.0k-$542.0k2024
Total assets$10.6k$10.6k2024
Liabilities$3.8M$3.8M2024
Equity-$3.8M-$3.8M2024
Revenue trend
FY2012 – FY2024 · USD
FY12
FY13
FY20
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is THC Therapeutics, Inc.’s revenue?
THC Therapeutics, Inc. booked $0 in FY2024 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Petlife Pharmaceuticals, Inc.——Bright Green Corporation——Wellness Matrix Group, Inc.——Health Advance Inc.——Transnational Cannabis Ltd.——Spencer Pharmaceutical Inc.——Neighbors
Clark →Key facts
CEOScott A. Cox
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLas Vegas, NV
ExchangeOTC: THCT
Employees1
IPO date2017-01-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.